• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

霍乱毒素分子及其亚基的大小和结构。

Size and structure of the cholera toxin molecule and its subunits.

作者信息

Ohtomo N, Muraoka T, Tashiro A, Zinnaka Y, Amako K

出版信息

J Infect Dis. 1976 Mar;133 Suppl:31-40. doi: 10.1093/infdis/133.supplement_1.s31.

DOI:10.1093/infdis/133.supplement_1.s31
PMID:815449
Abstract

Cholera toxin (choleragen) dissociated into two types of subunit with molecular weights estimated to be 28,000 daltons (A) and 11,000 daltons (B); this dissociation was effected by gel filtration at acid pH with or without urea. Subunit A could be separated into two fragments, A1 (23,000 daltons) and A2 (about 2,500 daltons), after reduction and alkylation. Choleragenoid (68,000 daltons) appeared to be a polymerized form of subunit B. A-specific antigen was found in choleragen as well as in A1 and A2, while B-specific antigen was found in both choleragen and choleragenoid. In electron micrographs, the toxin molecule appeared as a particle of uniform size consisting of subunits in V- or Y-shape and in ring form. The dimensions coincided with the values calculated from the molecular weights.

摘要

霍乱毒素(霍乱原)可解离为两种亚基,分子量估计分别为28,000道尔顿(A)和11,000道尔顿(B);这种解离可通过在酸性pH值下进行凝胶过滤来实现,有无尿素均可。在还原和烷基化后,亚基A可分离为两个片段,A1(23,000道尔顿)和A2(约2,500道尔顿)。类霍乱原(68,000道尔顿)似乎是亚基B的聚合形式。在霍乱毒素以及A1和A2中均发现了A特异性抗原,而在霍乱毒素和类霍乱原中均发现了B特异性抗原。在电子显微镜照片中,毒素分子呈现为大小均匀的颗粒,由呈V形或Y形以及环形的亚基组成。其尺寸与根据分子量计算的值相符。

相似文献

1
Size and structure of the cholera toxin molecule and its subunits.霍乱毒素分子及其亚基的大小和结构。
J Infect Dis. 1976 Mar;133 Suppl:31-40. doi: 10.1093/infdis/133.supplement_1.s31.
2
Chemistry of cholera toxin: the subunit structure.霍乱毒素的化学性质:亚基结构
J Infect Dis. 1976 Mar;133 Suppl:23-30. doi: 10.1093/infdis/133.supplement_1.s23.
3
The subunits of cholera toxin: structure, stoichiometry, and function.
J Infect Dis. 1976 Mar;133 Suppl:5-13. doi: 10.1093/infdis/133.supplement_1.s5.
4
Oligomeric structure of cholera toxin: characteristics of the H and L subunits.霍乱毒素的寡聚体结构:H亚基和L亚基的特征
J Gen Microbiol. 1975 Jan;86(1):49-65. doi: 10.1099/00221287-86-1-49.
5
Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.实验性霍乱的发病机制。霍乱毒素和类霍乱毒素的制备与分离。
J Exp Med. 1969 Jul 1;130(1):185-202. doi: 10.1084/jem.130.1.185.
6
Subunit structure of cholera toxin.霍乱毒素的亚基结构。
J Gen Microbiol. 1973 Jun;76(2):417-27. doi: 10.1099/00221287-76-2-417.
7
[Immunochemical analysis of the cytoplasmic fraction of a cholera-like vibrion].[霍乱样弧菌胞质部分的免疫化学分析]
Zh Mikrobiol Epidemiol Immunobiol. 1975 Jan(1):8-13.
8
Purification of cholera toxin and its subunits: new methods of preparation and the use of hypertoxinogenic mutants.霍乱毒素及其亚基的纯化:制备新方法及高毒素生成突变体的应用
Infect Immun. 1978 May;20(2):552-8. doi: 10.1128/iai.20.2.552-558.1978.
9
Studies of the subunit structure of choleragen.霍乱毒素亚基结构的研究。
Eur J Biochem. 1975 Sep 1;57(1):309-16. doi: 10.1111/j.1432-1033.1975.tb02302.x.
10
Binding of cholera toxin to mucins and inhibition by gastric mucin.
Infect Immun. 1974 Dec;10(6):1266-72. doi: 10.1128/iai.10.6.1266-1272.1974.

引用本文的文献

1
Label-free quantification of protein binding to lipid vesicles using transparent waveguide evanescent-field scattering microscopy with liquid control.使用带液体控制的透明波导倏逝场散射显微镜对与脂质囊泡结合的蛋白质进行无标记定量。
Biomed Opt Express. 2023 Jul 10;14(8):4003-4016. doi: 10.1364/BOE.490051. eCollection 2023 Aug 1.
2
Antibody binding reports spatial heterogeneities in cell membrane organization.抗体结合报告细胞膜组织的空间异质性。
Nat Commun. 2023 May 20;14(1):2884. doi: 10.1038/s41467-023-38525-2.
3
Evaluation of Cholera Toxin Adjuvanticity Effect on the Production of Specific Antibodies Induced by Avian Infectious Bronchitis Vaccine in Chickens.
评估霍乱毒素佐剂对鸡传染性支气管炎疫苗诱导特异性抗体产生的效果。
Arch Razi Inst. 2022 Feb 28;77(1):11-21. doi: 10.22092/ARI.2020.351673.1529. eCollection 2022 Feb.
4
Zinc oxide nanoparticles provide anti-cholera activity by disrupting the interaction of cholera toxin with the human GM1 receptor.氧化锌纳米颗粒通过破坏霍乱毒素与人GM1受体之间的相互作用来提供抗霍乱活性。
J Biol Chem. 2017 Nov 3;292(44):18303-18311. doi: 10.1074/jbc.M117.793240. Epub 2017 Sep 7.
5
The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses.霍乱毒素和不耐热肠毒素的催化A1结构域是强效DNA佐剂,可引发Th1/Th17混合细胞免疫反应。
Hum Vaccin Immunother. 2015;11(9):2228-40. doi: 10.1080/21645515.2015.1026498.
6
Adjuvant activity of the catalytic A1 domain of cholera toxin for retroviral antigens delivered by GeneGun.霍乱毒素催化性A1结构域对基因枪递送的逆转录病毒抗原的佐剂活性。
Clin Vaccine Immunol. 2011 Jun;18(6):922-30. doi: 10.1128/CVI.05019-11. Epub 2011 Apr 20.
7
Cholera toxin indirectly activates human monocyte-derived dendritic cells in vitro through the production of soluble factors, including prostaglandin E(2) and nitric oxide.霍乱毒素在体外通过产生可溶性因子,包括前列腺素E(2)和一氧化氮,间接激活人单核细胞衍生的树突状细胞。
Clin Vaccine Immunol. 2006 Jan;13(1):106-15. doi: 10.1128/CVI.13.1.106-115.2006.
8
Calcium signaling through phospholipase C activates dendritic cells to mature and is necessary for the activation and maturation of dendritic cells induced by diverse agonists.通过磷脂酶C的钙信号传导激活树突状细胞使其成熟,并且对于多种激动剂诱导的树突状细胞的激活和成熟是必需的。
Clin Diagn Lab Immunol. 2004 Jan;11(1):77-82. doi: 10.1128/cdli.11.1.77-82.2004.
9
An enzymatically active a domain is required for cholera-like enterotoxins to induce a long-lived blockade on the induction of oral tolerance: new method for screening mucosal adjuvants.霍乱样肠毒素诱导口服耐受产生长期阻断作用需要具有酶活性的A亚基:一种筛选黏膜佐剂的新方法。
Infect Immun. 2003 Dec;71(12):6850-6. doi: 10.1128/IAI.71.12.6850-6856.2003.
10
Cholera toxin and heat-labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cyclic AMP-dependent pathway.霍乱毒素和不耐热肠毒素激活人单核细胞衍生的树突状细胞,并通过环磷酸腺苷依赖性途径显著抑制细胞因子的产生。
Infect Immun. 2002 Oct;70(10):5533-9. doi: 10.1128/IAI.70.10.5533-5539.2002.